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Background: Toll-like receptors (TLRs) play an essential role in the activation of 
innate immunity and they can promote cancer cell survival and tumour progression. It 
has been claimed that TLRs can somehow predict the clinical behaviour in oral 
squamous cell carcinoma (OSCCs ).  
Aim: To elucidate the molecular basis underlying keratocystic odontogenic tumor 
(KOCTs) aggressive behaviour and recurrence we carried out this 
immunohistochemical study on TLR3 and TLR4 expression in sporadic primary  
KCOTs (sp-KCOTs), sporadic recurrent KCOTs (sp-KCOTs), and NBCCS-
associated KCOTs (NBCCS-KCOTs). 
Method: 40 cases of KOCTs removed from 23 men and 17 women were the sample. 
Paraffin-embedded blocks were processed for immunohistochemistry.  Sections were 
incubated with TLR3 and TLR4 antibodies and immunoreactivity evaluated on a 
semi-quantitative score. 
Results: Both TLR3 and TLR4 were expressed in KCOTs epithelium, although with a 
different extent. TLR3 was not expressed in sp-KCOTs and sr-KCOTs, but it showed 
a faint staining in NBCCS-KCOTs. On the other hand, both cytoplasmic and nuclear 
staining for TLR4 was detected in all the 3 types of lesions; however being 
significantly more expressed in sr-KCOT and NBCCS-KCOTs (p<0.0001). 
Our results, demonstrated an association between TLR4, but not TLR3 expression to 
recurrence behaviour of KCOTs. In fact, TLR4 was up-regulated in sr-KCOTs and 
NBCCS-KCOTs but not in sp-KCOTs. 
Conclusions: According these findings it seems conceivable to assume that the up-
regulation of TLR4 in some KCOTs can be correlated somehow to their tendency 
recurrence. 
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INTRODUCTION 
 
Keratocystic odontogenic tumor (KCOT), previously called odontogenic 
keratocyst (OCK), is a developmental cyst characterized by an aggressive 
nature and high rate of recurrence, especially compared with other 
odontogenic cysts (Ahmed Haji Omar et al., 2014; Shear, 2002a; b; c). 
KCOTs are normally sporadic primary lesions (sp-KCOTs), but they can be 
associated with nevoid basal cell carcinoma syndrome (NBCCS-KCOTs), in 
which case multiple lesions can be present. Interestingly, these two varieties of 
KOCTs are known to differ in their biological behaviour, i.e., in regard to 
growth speed and recurrence rate, as outlined in previous studies (Shear, 
2002c). In fact, even though recurrence rates are capricious and have been 
reported to vary from 2.5% to 62.5%, they are generally higher in NBCCS-
KCOTs (Woolgar et al., 1987a; b). 
To date, many efforts have been carried out to determine the reasons for these 
high recurrence rates and aggressive behaviour. Consequently, many studies 
have been performed to identify predictive factors that could elucidate the 
behaviour of KCOTs. These studies have dealt with clinical and histological 
factors as well as molecular pathways (Leonardi et al., 2010; Leonardi et al., 
2013; Lo Muzio et al., 2005; Shear, 1985; 2002b; Woolgar et al., 1987b). 
According to several investigations, differences in cellular proliferation rates 
and/or in the expression of oncoproteins and tumour suppressor genes have 
been described (de Paula et al., 2000; Lin et al., 2005), being much more 
highly expressed in NBCCS-KCOTs than in sp-KCOTs. However, whether 
these factors and, especially, epigenetic alterations are really related to KCOTs 
behaviour is a question that is still not answered (Gomes et al., 2009). 
Several studies have addressed the relevance of innate immune response in 
cancer progression, as it has been argued that tumour progression could be 
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partly due to a failure of the innate immune response (Duray et al., 2010). 
Toll-like receptors (TLRs) have recently been reported to play an essential role 
in the activation of innate immunity. These receptors are expressed in a large 
number of immune cells as well as nonimmune cells such as epithelial cells 
(Zhang et al., 2009), and they are also present in many types of cancer. 
To date, 11 human TLRs have been identified. There are two kinds of ligands 
for TLRs: exogenous pathogen–associated molecular patterns (PAMPs), 
which are components of microbes, and endogenous damage–associated 
molecular patterns (DAMPs), released from injured or inflamed tissues 
(Ioannou and Voulgarelis, 2010). Hence, the TLR-mediated immune response 
can be activated in the absence of foreign microbes (Tsan and Gao, 2004). 
DAMPs can be released from cells that have been affected by various stimuli 
and have entered a potentially neoplastic phase, as well as from cells that have 
undergone malignant transformation. On these premises, a large number of 
studies have investigated the role of TLRs in the pathogenesis of a range of 
malignant neoplasms (Bodelon et al., 2014; Rich et al., 2014). 
As far as head and oral cavity tissues are concerned, some interesting studies 
have pointed out the role in TLRs to predicting the clinical behaviour of these 
types of cancer. According to these researches, an up-regulation of TLR5 
activity may lead to more aggressive, invasive behaviour of oral carcinoma 
compared to skin cancer (Omar et al., 2014). Furthermore, another study 
demonstrated that the pattern of expression of TLR4 and TLR9 increased 
significantly from mild to severe oral epithelial dysplasia (OED), reflecting the 
progression of OED in oral squamous cell carcinoma (Kotrashetti et al., 2013). 
Also, a high/strong expression of TLR2, TLR4, and TLR9 seems to predict an 
invasive tumour growth of oral tongue squamous cell carcinoma (OTSCC) 
(Makinen et al., 2014). 
Considering the roles of TLRs, in an attempt to elucidate the molecular basis 
underlying KOCTs aggressive behaviour and recurrence, we carried out this 
immunohistochemical study on TLR3 and TLR4 expression in sporadic 
primary  KCOTs, sporadic recurrent KCOTs, and NBCCS-associated KCOTs. 
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MATERIAL AND METHODS 
Specimens 
After receiving approval by each institutional ethics committee, 40 cases of 
KOCTs were retrieved from the files of the Oral Pathology Unit, School of 
Dentistry, University of Birmingham, UK; the Faculdade De Odontologia 
Laboratório De Patologia Cirúrgica Universidade Federal Da Bahia, Brazil; 
and Pathological Anatomy, University of Foggia, Italy. The KOCTs were 
surgically removed from 23 men and 17 women with a mean age (± standard 
deviation) of 32 ± 8.7 years; range, 16–49). A total of 36 KOCTs were in the 
mandible and four in the maxilla. All of the lesions were treated with the same 
Partch II surgical approach. The lesions (Leonardi et al., 2010) were classified 
as sporadic primary KCOTs (sp-KCOT, n = 19) if they were not treated 
previously; as sporadic recurrent KCOTs (sr-KCOT, n = 9) if the lesions 
recurred more than 1 year after the first surgical intervention (follow-up period 
of 2–5 years); and as NBCCS-associated KCOTs (NBCCS-KCOT, n = 12) if 
the patients fulfilled two of the four major criteria or one major and two minor 
criteria required for NBCCS diagnosis (Evans and Farndon, 1993; High and 
Zedan, 2005). Clinicopathological diagnosis of NBCCS has been further 
confirmed by molecular analysis showing PTCH gene mutations as evaluated 
by previously described methods (Pastorino et al., 2005). All pathological 
diagnoses were made comparing the clinical, radiological, and histological 
data; all conformed to the parameters recommended by Kimonis (Kimonis et 
al., 1997) and Kramer and the World Health Organization classification of 
odontogenic cysts and tumors (Barnes L et al., 2005; Kramer, 1992). 
Noninflamed follicular dentigerous cysts (DC, n = 7) served as controls. 
 
Immunohistochemistry 
Serial sections (4 µm) from formalin-fixed, paraffin-embedded blocks of 
representative areas of cysts were cut for each case. Only sections containing 
sufficient epithelium to assess the antibody reactivity of 200 cells were 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
considered for this study. Sections were mounted on poly-L-lysine–coated 
glass slides.  
Antibodies for TLR3 (TLR3.7; sc-32232), and TLR4 (H-80; sc-10741) were 
obtained from Santa Cruz Biotechnology. (Santa Cruz, California, USA). The 
dilution for each antibody was established based on negative and positive 
controls (1/10 for TLR3 and1/40 for TLR4,) Immunohistochemistry was 
performed on these sections using a Ventana Benchmark XT autostainer 
(Ventana Medical Systems, Tucson, Arizona, USA). Deparaffinization was 
done in xylene and rehydration with graded alcohol series. A standard linked 
streptavidin–biotin horseradish peroxidase technique (LSAB-HRP) technique 
with an iView DAB Detection Kit (Ventana Medical Systems, Tucson, 
Arizona, USA) was used as the staining detection system. Sections were 
counterstained with type-II Gill’s hematoxylin, dehydrated with ethanol, and 
permanently coverslipped. Positive controls for immunohistochemistry 
consisted of tissue sections of oral squamous cell carcinomas (OSCCs). A 
negative control was performed in all cases by substituting the primary 
antibody with normal mouse serum. 
 
Evaluation of immunohistochemistry 
The slides were examined under a light microscope (Olympus Cx31; Tokyo, 
Japan) at ×400 magnification. Immunoreactivity was evaluated by two expert 
pathologists who were blinded to the clinical–pathological data and scored by 
a semi-quantitative scale assigning cases to one of the four following 
categories 0 (0 to <5% immunostained cells), 1 (6% to <40% immunostained 
cells, 2 (41% to <70% immunostained cells), and 3 (>71% immunostained 
cells). The percentage of positive cells was determined from the analysis of 
200 cells in 10 random areas at ×40 magnification. For each patient, the 
highest immunoscore was selected for further statistical analysis. 
 
Statistical analysis 
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Means and standard deviations were obtained for the extent score (ES) for 
staining in each sample and for each antibody. The data were analyzed using 
the Kruskal–Wallis test, which allowed comparison of TLR3 and TLR4 
expression scores among epithelial linings of the 3 cyst types and in the DC. 
Statistical computation was conducted using SPSS release 16.0 (SPSS Inc., 
Chicago, Illinois, USA). 
 
RESULTS 
 
Histologically, the tumors showed a cystic space, lined with a uniform, 
parakeratinized squamous epithelium, 5 to 10 cell layers thick. The basal cells 
were aligned with vertically elongated nuclei at right angles to the basement 
membrane. Some cases showed subepithelial splits, epithelial buds, and 
satellite cysts.  In addition, discrete focal mononuclear inflammatory infiltrates 
were seen in 14 lesions. 
Both TLR3 and TLR4 were expressed in KCOTs epithelium, although to a 
different extent; furthermore, the pattern of immunoreactivity showed 
extensive variation among each type of lesions (Figure 1, Table 1).  TLR3 was 
not expressed in sp-KCOTs and sr-KCOTs. In NBCCS-KCOTs, TLR3 
showed a faint staining, mainly concentrated in scattered cells of the basal and 
para-basal layers, with no staining of the luminal layers. 
On the other hand, both cytoplasmic and nuclear staining for TLR4 was 
detected in all lesions qualitatively. Cytoplasmic staining was most 
pronounced in sp-KCOTs, whereas cytoplasmic and nuclear staining was most 
prominent in sr-KCOTs and NBCCS-KCOTs. In sp-KCOTs, immostaining 
was apparent in some scattered cells of the basal layer. In sr-KCOTs and 
NBCCS-KCOTs, almost every cell of the basal and para-basal layers was 
immunolabeled by anti-TLR4 antibody. In some instances also, the basal third 
of epithelial layer was immunopositive for TLR4 antibody. 
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There were no statistically significant differences in the expression of TLR3 
among NBCCS-KOCTs, sr-KOCTs, sp-KOCTs, and DC (p = 0.0517). On the 
other hand, TLR4 ES showed a statistically significant difference (p < 0.0001) 
in the three cyst types, being more expressed in sr-KCOT and NBCCS-
KCOTs, versus sp-KOCTs and DC (Table 1). Details of TLR3 and TLR4 
expression in KCOTs and DC are given in Figures 1 and 2.  
 
 
 
DISCUSSION 
 
KCOT is an aggressive cystic lesion. Furthermore, although some OKC 
tumors do not recur after marsupialization or other conservative approaches, 
some lesions show aggressive behaviour. Several attempts have been made to 
elucidate this biologic behaviour, and investigations have tried to identify the 
molecular basis underlying the tendency of these lesions toward recurrence. 
Studies have demonstrated a high proliferative activity of these lesions and the 
expression of proteins associated with the inhibition of apoptosis. However, 
research  has dealt with TLRs, which have been demonstrated to play a crucial 
role in cancer cells: in fact, they can promote cancer cell survival and tumor 
progression. In accordance, we carried out this immunohistochemical study 
with the intent to correlate any possible associations between TLR3 and TLR4 
in sp-KCOTs, sr-KCOTs, and NBCCS-KCOTs, to improve the knowledge of 
the underlying mechanisms behind the aggressiveness of the disease as well as 
to provide new predictive markers that could be of assistance in choosing 
treatment modalities (Gomes et al., 2009; Luo et al., 2012). 
Among the family of TLRs, the present study has included TLR3 and TLR4, 
because they have been significantly associated with a higher probability of 
biochemical recurrence in prostate carcinomas (Gonzalez-Reyes et al., 2011), 
and they are up-regulated in oral squamous cell carcinoma (OSCC) and oral 
tongue squamous cell carcinoma (OTSCC) (Ahmed Haji Omar et al., 2014; 
Kotrashetti et al., 2013; Luo et al., 2012; Rich et al., 2014). However, for the 
sake of clarity, it should be underlined that both TLR3 and TLR4 can act as 
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pro-tumorigenic, with their signals mediating tumor invasion and metastasis 
by enhancing cell migration; meanwhile, they can have also an anticancer 
effect in some situations (Rich et al., 2014). 
Our results demonstrated an association between TLR4, but not TLR3, and 
recurrence behaviour of KCOTs. In fact, TLR4 was up-regulated in sr-KCOTs 
and NBCCS-KCOTs but not in sp-KCOTs and DC; on the other hand, a faint 
expression of TLR3 was observed in the 3 KCOT types and DC. According to 
our findings, it can be postulated that TLR3, being down-regulated in KCOTs, 
cannot induce apoptosis as described for some cancer cells (Luo et al., 2012; 
Salaun et al., 2006); on the other hand, it has been found that activation of 
TLR4 signalling results in increased growth of those cancer cells (Kelly et al., 
2006). 
In fact, TLR3, like Fas, can engage the extrinsic apoptotic machinery through 
the recruitment of caspase-8 to itself (Estornes et al., 2012). Furthermore, it 
has been demonstrated that ligation of TLR3 with its agonist directly reduces 
the viability of OSCC cells also (Luo et al., 2012) 
On the other hand, TLR4 expressed on cancer cells can suppress the antitumor 
functions of infiltrating immune cells and can thus alter the inflammatory 
response in a manner that promotes cancer progression (Nair et al., 2013). 
Furthermore, in some instances, the expression levels of TLR4 in situ seems to 
be correlated with tumor differentiation (Sun et al., 2012), in that that poorly 
differentiated tumors expressed little TLR4. Accordingly, TLR4 is highly 
expressed in well-differentiated and moderately well–differentiated tumors. In 
this respect, it has been reported that the expression of TLR4 increased with 
increasing degrees of OED (Kotrashetti et al., 2013), and its up-regulation 
reflected the progression of OED to OSCC. High expression of TLR4 has been 
demonstrated in well-differentiated and moderately differentiated carcinomas 
(WDSCCs and MDSCCs), whereas on poorly differentiated carcinomas 
(PDSCCs) there was only a faint expression. Similar results were obtained in 
separate immunohistochemical studies conducted by Szczepanski et al. 
(Szczepanski et al., 2009) on head and neck cancers and on oral cancer, in 
which a strong positive reaction for TLR4 was characteristic for well-
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differentiated or moderately differentiated tumours relative to moderate or 
weak staining intensity in poorly differentiated tumours (Nair et al., 2013). 
TLR4 has been associated also with the invasive potential of early-stage 
OTSCC (Makinen et al., 2014).  
The net effect of TLR4 signalling activation by its respective ligands results in 
activation of transcriptional factors such as nuclear factor–κB (NF-κB) and 
activator protein 1 (AP-1) through myeloid differentiation factor 88 (MyD88) 
–dependent and MyD88-independent pathways (Rich et al., 2014). NF-κB 
regulates, in turn, the expression of various genes, the products of which are 
involved in tumorigenesis (Basith et al., 2012; de Andrade Santos et al., 2011).  
Interestingly, it has been reported in a previous study that the more aggressive 
biologic behavior of OKCs, compared with radicular cysts (RC) and 
dentigerous cysts (DC) is related to the higher expression of NF-κB in these 
lesions (de Andrade Santos et al., 2011).  
For the sake of clarity, it should be mentioned that there is a drawback in our 
study. Tissue from primary KCOTs, before becoming a recurrent lesion, was 
not available; thus we carried out our investigation in sp-KCOTs and sr-
KCOTs, which were not paired. However, findings from this research may 
prompt further studies; in fact, in future investigations it will be worthwhile to 
evaluate both and compare the paired findings. 
 
CONCLUSION 
 
Based on our findings, it can be hypothesed that the up-regulation of TLR4 in 
some KCOTs can be correlated with their tendency toward recurrence. This 
finding can improve the current knowledge of molecular pathways involved in 
KCOTs and in some way help oral surgeons to predict which lesions will or 
will not recur. 
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Figure 1. Immunohistochemistry for TLR3 and TLR4 in sporadic primary 
KCOTs (sp-KCOTs), sporadic recurrent KCOTs (sr-KCOTs), and NBCCS-
associated KCOTs (NBCCS-KCOTs) at magnifications of ×100 and ×400.  
Figure 2. Immunohistochemistry for TLR3 (A) and TLR4 (B) in noninflamed 
follicular dentigerous cyst (DC), at a magnification of ×400. An 
immunoreaction product is apparent. 
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 TLR3 TLR4 
DC 0.179 ± 0.46 0.187 ± 0.53 
sp-KCOTs 0.117 ± 0.33 0.470 ± 0.51 
sr-KCOTs 0.444 ± 0.52 2.333 ± 0.50 
NBCCS-KCOTs 0.666 ± 0.22 2.417 ± 0.51 
 
Table 1. Means and standard deviations obtained respectively for each 
antibody in dentigerous cysts (DC),  sporadic primary keratocystic 
odontogenic tumors (sp-KCOTs), sporadic recurrent keratocystic odontogenic 
tumors (sr-KCOTs), and nevoid basal cell carcinoma syndrome–associated 
keratocystic odontogenic tumors (NBCCS-KCOTs). 
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